CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

IDH1/IDH2 mutation (low-grade glioma)

Gene: IDH1/IDH2 · Type: mutation

Indications: Glioma

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
VorasidenibGliomaINDICATED
FDA Label
Label